Approval · Notice of Compliance 35295 · 2025
TZIELD: Notice of Compliance 35295
Issued May 5, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 35295
- Date
- May 5, 2025
- Company
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TZIELD | 02557347 | Marketed |
Medicinal ingredients
- TEPLIZUMAB 2 MG per 2ML